OTCMKTS:SNYNF Sanofi 10/30/2026 Earnings Report $77.98 -2.37 (-2.95%) As of 10/2/2026 02:22 PM Eastern Profile Sanofi EPS ResultsActual EPSN/AConsensus EPS $2.78Beat/MissN/AOne Year Ago EPSN/ASanofi Revenue ResultsActual RevenueN/AExpected Revenue$15.20 billionBeat/MissN/AYoY Revenue GrowthN/ASanofi Announcement DetailsQuarterDate10/30/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesCompany Profile Sanofi Earnings HeadlinesDeutsche Bank Sticks to Its Buy Rating for Sanofi (SNYNF)September 15, 2026 | theglobeandmail.comRBC Capital Initiates a Hold Rating on Sanofi (SNYNF)September 9, 2026 | theglobeandmail.comThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story. | Stansberry Research (Ad)Sanofi (SNYNF) Gets a Hold from UBSAugust 20, 2026 | theglobeandmail.comAnalysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Ligand Pharma (LGND) and Exelixis (EXEL)August 12, 2026 | theglobeandmail.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Qiagen (QGEN) and Sanofi (OtherSNYNF)August 8, 2026 | theglobeandmail.comSee More Sanofi Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sanofi? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanofi and other key companies, straight to your email. Email Address About SanofiSanofi (OTCMKTS:SNYNF) is a France-based global biopharmaceutical company that researches, develops, manufactures and markets medicines and vaccines. Its portfolio focuses on immunology, rare diseases, vaccines, specialty care and established prescription medicines, serving patients and healthcare providers in markets around the world. The company’s products include Dupixent for several inflammatory conditions, Beyfortus for the prevention of respiratory syncytial virus disease in infants, and vaccines for influenza, meningococcal disease, polio and other conditions. Sanofi also offers treatments across areas such as diabetes, cardiovascular disease, oncology and rare diseases. Sanofi traces its roots to French pharmaceutical businesses established during the 20th century and became Sanofi-Aventis following the 2004 acquisition of Aventis. The company adopted the Sanofi name in 2011. Its global operations span research, manufacturing and commercial activities across North America, Europe, Asia and other international markets. Sanofi is led by Chief Executive Officer Paul Hudson.View Sanofi ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes Next Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
